Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 2, 2007, Pages 230-237

  Antachopoulos, Charalampos ^a   Meletiadis, Joseph ^a   Sein, Tin ^a   Roilides, Emmanuel ^a,b   Walsh, Thomas J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Aspergillus spp; Metabolic activity; XTT

Indexed keywords

AMPHOTERICIN B; MENADIONE; TETRAZOLIUM; VORICONAZOLE; 2,3 BIS(2 METHOXY 4 NITRO 5 SULFOPHENYL) 5 ((PHENYLAMINO)CARBONYL) 2H TETRAZOLIUM HYDROXIDE; 2,3-BIS(2-METHOXY-4-NITRO-5-SULFOPHENYL)-5-((PHENYLAMINO)CARBONYL)-2H-TETRAZOLIUM HYDROXIDE; ANTIFUNGAL AGENT; UNCLASSIFIED DRUG;

ABSORPTION; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; CONTROLLED STUDY; FUNGAL BIOMASS; FUNGAL METABOLISM; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; INCUBATION TEMPERATURE; INCUBATION TIME; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REFERENCE VALUE; REPRODUCIBILITY; SIGNAL TRANSDUCTION; SPECTROPHOTOMETRY; BIOMASS; COLORIMETRY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; METABOLISM; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; SENSITIVITY AND SPECIFICITY; TIME;

ANTIFUNGAL AGENTS; ASPERGILLUS; BIOMASS; COLORIMETRY; MICROBIAL SENSITIVITY TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TETRAZOLIUM SALTS; TIME FACTORS; VITAMIN K 3;

EID: 33947492793     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl488     Document Type: Article

References (32)

1. Hope WW, Denning DW. Invasive aspergillosis: Current and future challenges in diagnosis and therapy. Clin Microbiol Infect 2004; 10: 2-4.
2. Marr KA, Carter RA, Crippa F et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-17.
3. Lewis RE, Wiederhold NP, Lionakis MS et al. Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center. J Clin Microbiol 2005; 43: 6120-2.
4. Trullas JC, Cervera C, Benito N et al. Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients. Transplant Proc 2005; 37: 4091-3.
5. Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42: 4419-31.
6. Warris A, Weemaes CM, Verweij PE. Multidrug resistance in Aspergillus fumigatus. N Engl J Med 2002; 347: 2173-4.
7. Mellado E, Garcia-Effron G, Alcazar-Fuoli L et al. Substitutions at methionine 220 in the 14α-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother 2004; 48 2747-50.
8. Balajee SA, Weaver M, Imhof A et al. Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals. Antimicrob Agents Chemother 2004; 48: 1197-203.
9. Balajee SA, Gribskov JL, Hanley, E et al. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell 2005; 4: 625-32.
10. Howard SJ, Webster I, Moore CB et al. Multi-azole resistance in Aspergillus fumigatus. Int J Antimicrob Agents 2006; 26: 450-3.
11. Mellado E, Alcazar-Fuoli L, Garcia-Effron G et al. New resistance mechanisms to azole drugs in Aspergillus fumigatus and emergence of antifungal drugs-resistant A. fumigatus atypical strains. Med Mycol 2006; 44 Suppl: 367-71.
12. Chamilos G, Kontoyiannis DP. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resist Updat 2005; 8 344-58.
13. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi: Approved Standard. NCCLS, Pennsylvania, PA, USA, 2002.
14. Espinel-Ingroff A, Bartlett M, Bowden R et al. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol 1997; 35: 139-43.
15. Merz WG, Fay D, Thumar B et al. Susceptibility testing of filamentous fungi to amphotericin B by a rapid radiometric method. J Clin Microbiol 1984; 19: 54-6.
16. Balajee SA, Marr KA. Conidial viability assay for rapid susceptibility testing of Aspergillus species. J Clin Microbiol 2002; 40 2741-5.
17. Balajee SA, Imhof A, Gribskov JL et al. Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay. J Antimicrob Chemother 2005; 55: 102-5.
18. Wetter TJ, Hazen KC, Cutler JE. Modification of rapid susceptibility assay for antifungal susceptibility testing of Aspergillus fumigatus. J Clin Microbiol 2003; 41: 4252-8.
19. Meletiadis J, te Dorsthorst DT, Verweij PE. Use of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi. J Clin Microbiol 2003; 41: 4718-25.
20. Antachopoulos C, Meletiadis J, Roilides E et al. Relationship between metabolism and biomass of medically important zygomycetes. Med Mycol 2006; 44: 429-38.
21. Antachopoulos C, Meletiadis J, Roilides E et al. Rapid susceptibility testing of medically important zygomycetes by XTT assay. J Clin Microbiol 2006; 44: 553-60.
22. Meletiadis J, Mouton JW, Meis JF et al. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol 2001; 39 4256-63.
23. Meletiadis J, Mouton JW, Meis JF et al. Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol 2001; 39: 3402-8.
24. Klohn PC, Neumann HG. Impairment of respiration and oxidative phosphorylation by redox cyclers 2-nitrosofluorene and menadione. Chem Biol Interact 1997; 106: 15-28.
25. Chen Q, Cederbaum AI. Menadione cytotoxicity to Hep G2 cells and protection by activation of nuclear factor-κB. Mol Pharmacol 1997; 52: 648-57.
26. Niemczyk E, Majczak A, Hallmann A et al. A possible involvement of plasma membrane NAD(P)H oxidase in the switch mechanism of the cell death mode from apoptosis to necrosis in menadione-induced cell injury. Acta Biochim Pol 2004; 51: 1015-22.
27. Zadzinski R, Fortuniak A, Bilinski T et al. Menadione toxicity in Saccharomyces cerevisiae cells: Activation by conjugation with glutathione. Biochem Mol Biol Int 1998; 44: 747-59.
28. Tunney MM, Ramage G, Field TR et al. Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2004; 48: 1879-81.
29. Groll AH, Gea-Banacloche JC, Glasmacher A et al. Clinical pharmacology of antifungal compounds. Infect Dis Clin North Am 2003; 17: 159-91, ix.
30. Scheven M, Schwegler F. Antagonistic interactions between azoles and amphotericin B with yeasts depend on azole lipophilia for special test conditions in vitro. Antimicrob Agents Chemother 1995; 39: 1779-83.
31. Vanden Bossche H, Marichal P, Gorrens J et al. Biochemical approaches to selective antifungal activity. Focus on azole antifungals. Mycoses 1989; 32 Suppl 1: 35-52.
32. Lass-Florl C, Denning D, Rodriguez-Tudela JL. Status of susceptibility testing in Aspergillus. In: Abstracts of the Second Advances Against Aspergillosis, Athens, Greece, 2006, pp. 51-2.